![](https://www.udayavani.com/wp-content/uploads/2025/02/net-India-pti-fiel-415x233.png)
![](https://www.udayavani.com/wp-content/uploads/2025/02/net-India-pti-fiel-415x233.png)
PTI, Sep 13, 2021, 8:24 PM IST
New Delhi: The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.
Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.
The Centre had told Rajya Sabha in July that all documents required for the WHO’s Emergency Use Listing (EUL) have been submitted by Bharat Biotech as of July 9, and the global health body had commenced the review process.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
PM didn’t tell his good friend about country’s outrage over handcuffing Indian deportees: Congress
Maha Kumbh: Akhilesh seeks compensation to kin of devotees killed in accidents
Two held in Rs 850 crore ponzi scheme case: Cyberabad Police
Delhi stampede: Opposition blames govt for ‘gross mismanagement’, demands Vaishnaw’s resignation
Passengers got confused between ‘Prayagraj Express, Prayagraj Special’, causing stampede: Officials
India Nets: Shami works on lengths with Morkel, Pant recovers after freak hit by Hardik shot
To ban or not to ban? Countries debate regulations on smartphone usage in schools
PM didn’t tell his good friend about country’s outrage over handcuffing Indian deportees: Congress
Maha Kumbh: Akhilesh seeks compensation to kin of devotees killed in accidents
“Namma Sante” buzz: From coconut shell art to pure honey delights!
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.